Gilbert Halley E
- SEC CIK
- 0001601360
In the past year, 1 open-market sale filing worth $455.5K and no purchases.
Current role at each company
- CTMX CytomX Therapeutics, Inc.Directoras of Jun 22, 2026
- PCVX Vaxcyte, Inc.Directoras of Jun 16, 2026
- ARQT Arcutis Biotherapeutics, Inc.Directoras of Jun 9, 2026
- NEO Neogenomics IncChief Legal Officeras of Mar 3, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $455.5K
- 1 filing
- Net
- −$455.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Gilbert Halley E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARQT Arcutis Biotherapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 (view filing) | Nov 20 | 1 day | Gilbert Halley EDirector | SSale | −16.5K | $27.55 | −$455.5K | −42.8%22.1K after |
PCVX Vaxcyte, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2024 (view filing) | Jun 3 | 2 days | Gilbert Halley EDirector | SSale | −18.2K | $73.00 | −$1.33M | −76.4%5.63K after | 10b5-1 |